REG endpoint validation: Do database asthma control measures predict future risk?
G. Brusselle, R. J. Martin, A. Burden, A. Dima, E. Pizzichini, J. Holbrook, N. G. Papadopoulos, T. Popov, G. Colice, H. K. Reddel, J. von Ziegenweidt, A. Chisholm, D. Price (Ghent, Florianópolis, Belgium; Denver, Baltimore, Washington, United States Of America; Cambridge, Aberdeen, United Kingdom; Amsterdam, Netherlands; Athens, Greece; Sofia, Bulgaria; Sydney, Australia)
Source: International Congress 2014 – Management of asthma and other respiratory diseases in primary care
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Brusselle, R. J. Martin, A. Burden, A. Dima, E. Pizzichini, J. Holbrook, N. G. Papadopoulos, T. Popov, G. Colice, H. K. Reddel, J. von Ziegenweidt, A. Chisholm, D. Price (Ghent, Florianópolis, Belgium; Denver, Baltimore, Washington, United States Of America; Cambridge, Aberdeen, United Kingdom; Amsterdam, Netherlands; Athens, Greece; Sofia, Bulgaria; Sydney, Australia). REG endpoint validation: Do database asthma control measures predict future risk?. Eur Respir J 2014; 44: Suppl. 58, 3022
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: